Mass General Brigham’s operating performance perked up in final months of 2020

More acutely ill patients and higher research revenue in the final months of 2020 helped Mass General Brigham nearly triple its operating income year-over-year.

The Boston-based system has struggled throughout the COVID-19 pandemic, but the quarter ended Dec. 31, 2020—the first quarter of its fiscal 2021—signaled it may be turning a corner. Mass General Brigham generated $130 million in operating income on $3.8 billion in revenue in the quarter, a 3.4% operating margin. That’s compared with a slimmer 1.3% margin in the prior-year period, when it generated just $45 million in operating income on $3.6 billion in revenue.

Most recently, the not-for-profit system, formerly known as Partners HealthCare, weathered a $351 million loss on operations in its fiscal 2020, which ended Sept. 30, 2020, a -2.5% margin. The biggest contributor, the system said, was the cancellation of non-essential procedures early on in the pandemic.

“In recent weeks, we have witnessed many of the leading indicators head in the right direction, and we hope we are seeing the beginning of the end,” Peter Markell, Mass General Brigham’s chief financial officer, said in a statement.

Mass General Brigham’s improved operating performance at the tail end of 2020 occurred entirely in its provider division, which generated $114 million in operating income, up from $55 million in the prior-year period.

The system attributed its higher patient revenue to more acutely ill COVID patients, who tend to have longer lengths of stay. That’s despite a nearly 7% year-over-year decline in discharges and lower outpatient volumes. Research revenue grew 6% in the quarter to $551 million. The system also got a $28 million boost from intellectual property monetization.

The system’s insurance division lost $14 million on operations in the quarter, or a -6.2% margin. That’s excluding a $30 million Affordable Care Act risk corridor settlement. The insurance division also lost money in the prior-year period, posting a -4.9% margin. Despite a 5% year-over-year uptick in premium revenue, medical claims costs grew 9% as patients returned for services, particularly outpatient and pharmaceutical.

While total plan membership increased 5%, that growth was higher in Medicaid managed care, which grew by 17%. California’s Kaiser Permanente late last week reported a slimmer operating margin, in part because the pandemic’s job losses had pushed more members onto government-sponsored plans.

Since the pandemic began, Mass General Brigham said it has encountered or tested more than 60,000 COVID patients, of which more than 16,000 were treated in its hospitals. Over the past month, the system has administered COVID vaccines to tens of thousands of healthcare workers and this week began vaccinating patients in accordance with state guidelines.

Mass General Brigham CEO Dr. Anne Klibanski said in a statement the vaccinations offer hope there is a path forward to control the pandemic.



Source link

Blog article

New conservative target: Race as factor in COVID treatment

Some conservatives are taking aim at policies that allow doctors to consider race as a risk factor when allocating scarce COVID-19 treatments, saying the protocols discriminate against white people. The wave of infections brought on by the omicron variant and a shortage of treatments have focused attention on the policies. Medical experts say the opposition […]

Read More
Blog article

CVS Caremark agrees to settlement over transaction fees

The Oklahoma Insurance Department has entered into a settlement agreement with CVS Caremark over transaction fees the pharmacy benefit manager charges pharmacists to process Medicare Part D and group health plan claims, the agency announced Thursday. The CVS Health subsidiary will pay $4.8 million to settle the alleged violations of the state’s Patient’s Right to […]

Read More
Blog article

How to choose a quality bong?

There are bongs around with just about any shape, size or color you can imagine. Unfortunately, most bongs on the market today do not live up to their expectations of smoothness and potency. The bong industry is flooded with bongs made of cheap glass with wild claims of functionality attached to them. Many users avoid […]

Read More